GENERAL COMMENTS
1) Introduction:
There are not so many positive findings about mindfulness interventions in BD (page 3) (see Chu et al. 2017) .
2) Outcomes (feasibility and acceptability)
Authors could define previously parameters to conclude that the intervention is feasible and acceptable. For example: how many sessions patients should attend?
3) Methods:
Inclusion criteria: Why authors have chosen including subjects from bipolar spectrum? Considering the sample size, it should be better being more conservative, including type I and II only. A broad diagnosis can interfere in the interpretation of the data.
Exclusion criteria: Authors should adopt a cut-off point in mood scales, avoiding including very symptomatic individuals.
4)
Outcomes:
There is a minimum number of sessions the patients must participate to be included in the analysis?
5) Statistical Methods:
Which level of significance will set for the study? 6) Table I: Some instruments described in the paper were not included in the Here a list of my comments (for minor revision): -Data management: How and at which time the pseudonymisation is planned? Is a cloud the best option (with regard to data security)?
-As described in limitations, the study involves a very small number of participants. It may be that the proposed sample size is within the range of related feasibility studies. However, the dropout ratio in studies with psychiatric disorder is high. Maybe it would be useful to increase the recruitment target. In addition, it is an advantage to consider differences of therapy-response related to various subgroups (such as gender and age).
Introduction:
Response: Thank you for drawing our attention to this recently published systematic review. We have now cited this systematic review and have also amended our wording to reflect the preliminary nature of findings regarding the potential impact of mindfulness based interventions in BD.
Outcomes (feasibility and acceptability)
Response: Thank you for your feedback. As this is the first time this group has been conducted, and we are therefore limited in our understanding of acceptable parameters for feasibility, we have decided not to pre-specify criteria. Rather, we will use the ADePT framework to comprehensively explore what worked well and what worked less well (within the three overarching domains of intervention, study design and setting/ context). We will use this information to identify and explore barriers to a large-scale evaluation, including what amendments and/ or information would be needed to improve the success of a follow-on evaluation and the (im)practicality of addressing these within a real world clinical context. We will then use this comprehensive evaluation of quantitative and qualitative data to make an informed decision regarding feasibility.
Methods:
Response: We agree that restricting inclusion to Bipolar I and/ or II would be more conservative given the proposed sample size. However, our decision to be more inclusive is guided by our intention of exploring feasibility and acceptability within a real-world setting. Primary care settings (a key referral source for privately delivered, government subsidised mental health care) are characterised by diagnostic heterogeneity, with participants across the bipolar spectrum accessing these services. Accordingly, we felt it important that our inclusion criteria reflect the range of individuals likely to be referred for mental health care.
In line with this, we have now clarified our decision to include adults from across the Bipolar Spectrum in the discussion section.
We agree that it is important to avoid conducting group therapy with very symptomatic individuals. However, relative to adopting a cut-off point in mood scales as the reviewer suggests, we intend to use criteria from the SCID-V and exclude participants if they meet criteria for a current mood episode. This decision was guided by the translational focus of the current study, in that it enables us to work with participants outside of an acute mood episode, but alongside the symptoms that often presist between episodes.
The discussion section has been updated accordingly to clarify our decision to utilise an acute mood episode relative to symptom score as an eligibility criterion.
Outcomes:
Response: We intend to include all data to inform our conclusions regarding feasibility and acceptability.
Statistical Methods:
Which level of significance will set for the study?
Response: Level of significance will be set at P < .05. The statistical methods section has been updated accordingly.
6. Table I : Some instruments described in the paper were not included in the Table I (the Recovery oriented Service Self-Assessment, for example)
Response: Table 1 details the schedule of assessments undertaken by study participants. The ROSSAT, CTS-R and Study Specific Checklist were not originally included as they are completed by study staff (the group facilitators and the independent fidelity assessor).
To improve clarity, a table has now been developed to reflect the schedule of these fidelity instruments (see table two, page 14).
